Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Literature
1.
2.
3.
Mansier O, Luque Paz D, Ianotto JC, et al. Clinical and biological characterization of MPN patients harbouring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) study. Am J Hematol. 2018;93:E84-6.CrossRef
Metadata
Title
Double-mutant myeloproliferative neoplasms
Author
Stephen E. Langabeer
Publication date
01-10-2018
Publisher
Springer US
Published in
Medical Oncology / Issue 10/2018
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-018-1200-x

Other articles of this Issue 10/2018

Medical Oncology 10/2018 Go to the issue

Short Communication

Sorafenib in patients with progressed and refractory bone tumors

Original Paper

Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma

Review Article

Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy

Original Paper

Pre-therapy CT scan showing peritoneal thickening from metastatic renal pelvis carcinoma patients

Review Article

Primary leiomyosarcoma of the skin: a comprehensive review on diagnosis and treatment

Expression of Concern

Expression of concern: Short hairpin RNA (shRNA) of type 2 interleukin-1 receptor (IL1R2) inhibits the proliferation of human osteosarcoma U-2 OS cells

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits